PARTNER PROGRAM SPONSOR
07:00 – 08:15
THURSDAY 16 JUNE
BREAKFAST SESSION 1
Innovative advancement in the assessment and evaluation of mTBI with biomarker-based testing
Join us as we explore an innovative technique for objective assessment of suspected mild traumatic brain injury (mTBI) in the ED using blood based biomarkers. We will also explore how they could be utilised to improve patient outcomes, patient flow in the ED and their potential place in clinical pathways – with Dr Gary Mitchell from Queensland Health.
Chair: Dr Jaime Marino, Associate Director Medical Affairs, Abbott Core Laboratories
Speaker: Dr Gary Mitchell, Queensland Health on:
Innovative technique for objective assessment of suspected mild traumatic brain injury (mTBI) in the ED using biomarkers
Advancements in Brain Injury Evaluation in the ED: How TBI biomarkers could change clinical evaluation of mTBI or How TBI Biomarkers could change TBI evaluation in the clinical setting
Chair: Chris Davlantes
Blurb about this Presenter
Chair: Dr Jaime Marino
MD, MBA
Associate Director Medical Affairs, Abbott
Dr. Jaime Marino is an Associate Director Medical Affairs at Abbott Core Laboratories. He is a physician with a Masters in Business Administration focused on Healthcare Administration and experience in pharmaceutical and diagnostic research. He has a tenure of 9 years at Abbott in Clinical and Medical Affairs.
Dr. Marino has led clinical studies for regulatory submission in a wide variety of disease states and also companion diagnostics studies for Phase II-IV in the US and also Outside of the US. He has led global research studies with companies and academic institutions in the neuro early research and discovery space. His work has allowed the filing of over 30 patents and included as inventor in over 8 patent applications. He has co-author several TBI biomarker publications.
Dr. Marino has led research studies that supported regulatory submissions to the FDA for Abbott Point of Care and Abbott Core Laboratory and breakthrough designations for TBI related biomarker claims. He has been invited as speaker and participant in TBI discussions with companies and academic institutions.
Dr. Marino has worked with TRACK-TBI, the DOD , and advocacy groups to make headway to new technologies to help improve the health care of patients that suffer traumatic brain injuries.
Chair: Dr Gary Mitchell
MB BAO FACEM
Current Appointments-
- Staff Specialist – Royal Brisbane and Women’s Hospital Emergency and Trauma Centre
- Senior Lecturer- University of Queensland
- Clinical Appointment- Jamieson Trauma Institute
- Queensland Rugby Union/ Australian Rugby Union – Match-day/Team Doctor
After completing undergraduate medical training at Queens University Belfast and after working in the UK NHS as a Junior Doctor, he moved to Brisbane and trained as a Specialist in Emergency Medicine. After completing his specialist training in emergency medicine, he then spent a year in Canada at the University of Calgary completing a fellowship in Pre-hospital and Disaster medicine.
He has an interest in TBI, specifically in concussion assessment and management. He chairs the JTI TBI advisory committee and sits on the Qld statewide brain and spinal cord injury committee. He is involved in multiple local, national and international trials on TBI ranging from clinical biomarkers, innovative technology, imaging and interventions.
Having played rugby union for Ireland and Ulster at various age-grades and club rugby in Ireland, Canada and Australia, he has stayed involved with the sport by working with numerous teams from grassroots to the international level and is passionate about translating professional concussion care to grassroots athletes.
